[Secretion of Th1-type cytokines and production of HBV-specific cytotoxic T lymphocytes in C57BL/6 mice induced by cytoplasmic transduction peptide-HBcAg18-27-Tapasin].
To observe whether the fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27;-Tapasin could induce Th1-type cytokine secretion and expression of hepatitis B virus (HBV)-specific cytotoxic T lymphocytes (CTL) in C57BL/6 mice. C57BL/6 mice were randomly divided into 4 groups, with 5 mice in each group. The mice of 4 groups were intramuscularly injected with the fusion protein CTP-HBcAg18-27;-Tapasin, CTP-HBcAg18-27;, HBcAg18-27;-Tapasin (50 μg) and normal saline, respectively. The levels of cytokines secreted by T lymphocytes were detected by ELISA and intracellular cytokine of proliferative T cells by flow cytometry. The proliferation of T lymphocytes was observed using CCK-8 assay. CTP-HBcAg18-27;-Tapasin not only induced significantly T lymphocyte proliferation, but also increased the production of cytokines (IFN-γ, IL-2) compared with CTP-HBcAg18-27; or HBcAg18-27;-Tapasin alone or normal saline. Moreover, CTP-HBcAg18-27;-Tapasin fusion protein increased significantly the percentages of IFN-γ(+);CD8(+); T cells. The CTP-HBcAg18-27;-Tapasin fusion protein can effectively stimulate the secretion of Th1-type cytokines, induce T lymphocyte proliferation and increase the expression of HBV-specific CTLs in C57BL/6 mice.